Log in to save to my catalogue

Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant...

Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9744121

Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

About this item

Full title

Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

Publisher

London: Nature Publishing Group UK

Journal title

Prostate cancer and prostatic diseases, 2022-04, Vol.25 (4), p.800-801

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Alternative Titles

Full title

Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9744121

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9744121

Other Identifiers

ISSN

1365-7852

E-ISSN

1476-5608

DOI

10.1038/s41391-021-00401-9

How to access this item